Wilms' Tumor Suppressor Gene (WT1) Suppresses Apoptosis by Transcriptionally Downregulating BAX Expression in Immature Rat Granulosa Cells
Overview
Reproductive Medicine
Authors
Affiliations
Background: The important role of WT1 in early folliculogenesis was evident from its restricted expression pattern in immature follicles and from its involvement in transcriptional control of inhibin-α and FSH receptor. There is also considerable evidence that WT1 is a potent inhibitor of apoptotic cell death in the developing kidney and male germ cells, suggesting that it could play a role in the regulation of follicle survival. Therefore, we evaluated if WT1 involves in cell survival of granulosa cells (GCs) during the FSH-independent stage.
Methods: GCs were obtained from small preantral follicles of immature rat ovary. Bax and bcl-2 mRNA and protein levels in GCs transfected with WT1 (-KTS) or WT1 (+KTS) were analyzed by Real-time RT-PCR and immune-blotting analysis. Cell viability was measured with MTT assays and apoptosis was analyzed with caspase 3/7 activity and TUNEL assay. The mechanism by which WT1 regulates Bax expression was investigated using Bax promoter-luciferase reporter assay and ChIP assays from GCs.
Results: Here, we showed that WT1 (-KTS) suppressed endogenous Bax transcript and protein expression, and this inhibition resulted from direct binding of WT1 in the Bax promoter region in vivo. In addition, anti-apoptotic effects of WT1 (-KTS) were demonstrated based on MTT assays, a sensitive bioluminescence caspase 3/7 assay and TUNEL assays. On the other hand, WT1 has no role on bcl-2 expression in GCs.
Conclusion: These findings suggest that activation of WT1 is necessary for maintenance of GC survival during early stage of follicles and WT1 can play a role in protecting apoptosis through the regulation of upstream activator (Bax), as well as through regulation of downstream effecter (caspases 3 and 7).
Wang Y, Chen Q, Zhang F, Yang X, Shang L, Ren S Mol Genet Genomic Med. 2021; 10(1):e1820.
PMID: 34845858 PMC: 8801142. DOI: 10.1002/mgg3.1820.
Li M, Xue L, Xu W, Liu P, Li F In Vitro Cell Dev Biol Anim. 2021; 57(8):775-785.
PMID: 34554376 PMC: 8585816. DOI: 10.1007/s11626-021-00609-y.
Wilms' tumor in a 51-year-old patient: An extremely rare case and review of the literature.
Hu J, Jin L, He T, Li Y, Zhao Y, Ding Y Mol Clin Oncol. 2016; 4(6):1013-1016.
PMID: 27313862 PMC: 4888037. DOI: 10.3892/mco.2016.839.